Clinical Trial Update: Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06

View source ↗

Summary

This update reports on the pharmacokinetics of asparaginase and the development of anti-asparaginase antibodies in the Interfant-06 leukemia trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Asparaginase (asparaginase)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Leukemia | Status: COMPLETED